Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Lilly presents novel MAP kinase p38 inhibitors

June 29, 2012

New formylpeptide receptor ligands patented by Allergan

June 29, 2012

Novel PARP inhibitors developed in China

June 29, 2012

New fusion proteins for bone disorders designed in Korea

June 28, 2012

Merck KGaA designs new hPDK1 inhibitors

June 28, 2012

Korean researchers present novel protein kinase inhibitors

June 28, 2012

Polish team describes new fusion proteins for cancer

June 28, 2012

Novel TRPV1 channel antagonists developed at GlaxoSmithKline

June 28, 2012

AstraZeneca patents novel agents for arrhythmia

June 28, 2012

Novel PI3K-alpha/mTORC1 inhibitors disclosed by Exelixis

June 28, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...